000 01032 a2200289 4500
005 20250518042104.0
264 0 _c20200214
008 202002s 0 0 eng d
022 _a1365-2036
024 7 _a10.1111/apt.15285
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOlaisen, Maya
245 0 0 _aEditorial: mesalamine and mucosal microbiome in quiescent ulcerative colitis-what can we learn? Authors' reply.
_h[electronic resource]
260 _bAlimentary pharmacology & therapeutics
_c06 2019
300 _a1532 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aAminosalicylic Acid
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
650 0 4 _aColitis, Ulcerative
650 0 4 _aDrug Compounding
650 0 4 _aHumans
650 0 4 _aMesalamine
650 0 4 _aMicrobiota
700 1 _aFossmark, Reidar
773 0 _tAlimentary pharmacology & therapeutics
_gvol. 49
_gno. 12
_gp. 1532
856 4 0 _uhttps://doi.org/10.1111/apt.15285
_zAvailable from publisher's website
999 _c29735395
_d29735395